153 related articles for article (PubMed ID: 25380351)
1. IMP-3 promotes migration and invasion of melanoma cells by modulating the expression of HMGA2 and predicts poor prognosis in melanoma.
Sheen YS; Liao YH; Lin MH; Chu CY; Ho BY; Hsieh MC; Chen PC; Cha ST; Jeng YM; Chang CC; Chiu HC; Jee SH; Kuo ML; Chu CY
J Invest Dermatol; 2015 Apr; 135(4):1065-1073. PubMed ID: 25380351
[TBL] [Abstract][Full Text] [Related]
2. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 2 mRNA-binding protein 3 enhanced melanoma migration through regulation of AKT1 and RELA expression.
Sheen YS; Syu YJ; Chang YC; Hsieh PH; Liao YH; Lin MH; Chen CY; Chu CY; Chu CY
Exp Dermatol; 2024 Jan; 33(1):e15015. PubMed ID: 38284203
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
5. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.
Wu J; Zhang S; Shan J; Hu Z; Liu X; Chen L; Ren X; Yao L; Sheng H; Li L; Ann D; Yen Y; Wang J; Wang X
Cancer Lett; 2016 Jul; 376(2):284-92. PubMed ID: 27063096
[TBL] [Abstract][Full Text] [Related]
6. High G2 and S-phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
Xu T; Ma M; Chi Z; Si L; Sheng X; Cui C; Dai J; Yu S; Yan J; Yu H; Wu X; Tang H; Yu J; Kong Y; Guo J
Cancer Sci; 2018 Jun; 109(6):1787-1798. PubMed ID: 29660787
[TBL] [Abstract][Full Text] [Related]
7. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
[TBL] [Abstract][Full Text] [Related]
8. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
9. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
[TBL] [Abstract][Full Text] [Related]
10. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC
Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962
[TBL] [Abstract][Full Text] [Related]
11. A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.
Dadras SS; Lin RJ; Razavi G; Kawakami A; Du J; Feige E; Milner DA; Loda MF; Granter SR; Detmar M; Widlund HR; Horstmann MA; Fisher DE
Am J Pathol; 2015 Jan; 185(1):252-65. PubMed ID: 25447045
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
13. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
[TBL] [Abstract][Full Text] [Related]
14. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
Xing F; Song Z; He Y
Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
17. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
18. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
Sun X; Xu M; Liu H; Ming K
Mol Med Rep; 2017 Sep; 16(3):3557-3564. PubMed ID: 28714014
[TBL] [Abstract][Full Text] [Related]
20. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]